Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

Novo Nordisk (NVO), the company behind Ozempic and Wegovy, announced that it will invest 6.4 billion reais (about $1.09 ...

Novo Nordisk has invested 6.4bn Brazilian reais ($1.09bn ... Located in Southeastern Brazil, the Montes Claros site is ...

Novo Nordisk (NVO), the company behind Ozempic ... Reinaldo Costa, the vice president of the Montes Claros factory, said this expansion will significantly increase the plant’s output, although ...

The most popular injectable drugs already on the market are made by Eli Lilly, which sells its drug as Zepbound for obesity and Mounjaro for diabetes, and Novo Nordisk, which sells its medicine as ...

COPENHAGEN (Reuters) - Novo Nordisk (CSE:NOVOb) said on Tuesday it had bought a factory in North Carolina that would assist in ...